Tracheobronchial Stent Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Metal Tracheobronchial Stents, and 1 more

Tracheobronchial Stent Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Metal Tracheobronchial Stents, and 1 more

The global market for tracheobronchial stents was valued at $216.3 million in 2022, with an anticipated decrease over the forecast period at a CAGR of -2.2%, ultimately reaching $185.7 million. The market report covers both metal and silicone tracheobronchial stents.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL TRACHEOBRONCHIAL STENT MARKET INSIGHTS

A significant factor driving the market growth is the preference for silicone stents over their metal counterparts. Unlike metal stents, which are permanently implanted in a patient's airways, silicone stents can be removed or replaced to mitigate potential complications for the patient.

GLOBAL TRACHEOBRONCHIAL STENT MARKET SHARE INSIGHTS

The Global tracheobronchial market was led by Getinge, Boston Scientific, and Merit Medical.
Getinge was the top player in the tracheobronchial stent industry, operating exclusively in the metal tracheobronchial stent category with its iCAST™ Balloon Expandable Covered Stent. However, it's worth mentioning that a significant portion of the product sales may be utilized off-label for peripheral vascular interventions such as iliac, for which the international variant of the stent, Advanta™ V12, has CE and regional clearance.

MARKET SEGMENTATION SUMMARY

Tracheobronchial Stent Market – MedCore – Includes:
Metal and silicone tracheobronchial stents.

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.